Glyxambi 25/5 mg Tablet - Empagliflozin and Linagliptin | Type 2 Diabetes Medicine


New member

Type 2 Diabetes (T2D) is a metabolic disorder and an inflammatory state that can put you at a higher-than-average risk of developing heart disease, chronic kidney disease (CKD), and a host of other common complications. If you control your blood glucose levels, the lower your chances of developing these health problems. That’s why it’s still so important to make adjustments to your diet and step up your physical activity. In addition to lifestyle changes, patients who are diagnosed with Type 2 diabetes are often prescribed an oral antidiabetic drug.

Brand Name : Glyxambi 25/5
Composition : Empagliflozin and Linagliptin
Manufactured by : Boehringer Ingelheim
Strength : Empagliflozin 25 mg and Linagliptin 5 mg
Form : Tablet
Packing : Pack of 90 Tablets

Glyxambi 25/5 mg tablet is a combination medicine of two antidiabetic drugs - Empagliflozin and Linagliptin. Empagliflozin works by removing excess glucose from your body through urine. Linagliptin works by lowering glucose production in the liver, delaying glucose absorption from the intestines, and increasing the body's sensitivity to insulin.

The main goals of Glyxambi tablet in type 2 diabetes are to keep your blood sugar levels within your goal range and treat other medical conditions that go along with diabetes. For getting more information about diabetes medicine price, uses, dosage, availability....visit Drugssquare Pharmacy or Call/Whatsapp +91-9958550955